KBC Group NV Cuts Stock Holdings in The Clorox Company $CLX

KBC Group NV reduced its position in The Clorox Company (NYSE:CLX) by 0.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 582,741 shares of the company’s stock after selling 4,938 shares during the period. KBC Group NV owned about 0.47% of Clorox worth $69,970,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Cerity Partners LLC grew its stake in shares of Clorox by 13.3% in the first quarter. Cerity Partners LLC now owns 63,499 shares of the company’s stock worth $9,350,000 after acquiring an additional 7,451 shares during the period. New York State Common Retirement Fund boosted its holdings in Clorox by 4.5% in the first quarter. New York State Common Retirement Fund now owns 75,087 shares of the company’s stock worth $11,057,000 after purchasing an additional 3,200 shares during the last quarter. CWM LLC grew its position in Clorox by 19.7% in the 1st quarter. CWM LLC now owns 36,194 shares of the company’s stock worth $5,330,000 after purchasing an additional 5,960 shares during the period. Apollon Wealth Management LLC raised its stake in Clorox by 4.1% during the 1st quarter. Apollon Wealth Management LLC now owns 3,502 shares of the company’s stock valued at $516,000 after buying an additional 138 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd bought a new position in shares of Clorox during the 1st quarter valued at $369,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CLX. Jefferies Financial Group reissued a “buy” rating and issued a $152.00 target price on shares of Clorox in a research report on Tuesday, November 4th. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday, November 4th. Citigroup reduced their target price on shares of Clorox from $130.00 to $120.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. Morgan Stanley dropped their price target on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Finally, The Goldman Sachs Group cut their price objective on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and an average price target of $125.69.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Trading Up 0.3%

Shares of CLX stock opened at $104.99 on Wednesday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock has a fifty day simple moving average of $118.92 and a two-hundred day simple moving average of $124.26. The firm has a market capitalization of $12.81 billion, a PE ratio of 16.10, a PEG ratio of 0.92 and a beta of 0.52. The Clorox Company has a 52-week low of $104.08 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s quarterly revenue was down 18.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were given a dividend of $1.24 per share. The ex-dividend date was Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.7%. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.